| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:Pazopanib Related Compound 2
CAS:1226500-02-2
Purity:> 95% Remarks:An impurity of Pazopanib whic is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FG
|
| Company Name: |
Nanjing XiZe Biotechnology CO., Ltd.
|
| Tel: |
025-58362220 15250997978 |
| Email: |
1511893459@qq.com |
| Products Intro: |
Product Name:Pazopanib Related Compound 2
CAS:1226500-02-2
Purity:95% HPLC Package:10mg;25mg;50mg;100mg;250mg;500mg;1g
|
|
| | Pazopanib Related Compound 2 Basic information |
| Product Name: | Pazopanib Related Compound 2 | | Synonyms: | Pazopanib Related Compound 2;Pazopanib Related Compound;2,4-Pyrimidinediamine, N2-(2-chloro-4-pyrimidinyl)-N2,N4-bis(2,3-dimethyl-2H-indazol-6-yl)-;N2-(2-Chloropyrimidin-4-yl)-N2,N4-bis(2,3-dimethyl-2H-indazol-6-yl)pyrimidine-2,4-diamine;Pazopanib Impurity 75 | | CAS: | 1226500-02-2 | | MF: | C26H23ClN10 | | MW: | 510.98 | | EINECS: | | | Product Categories: | | | Mol File: | 1226500-02-2.mol |  |
| | Pazopanib Related Compound 2 Chemical Properties |
| Boiling point | 844.7±75.0 °C(Predicted) | | density | 1.45±0.1 g/cm3(Predicted) | | pka | 2.60±0.30(Predicted) |
| | Pazopanib Related Compound 2 Usage And Synthesis |
| Uses | This compound is an impurity of Pazopanib (P210925). Pazopanib is an oral angiogenesis inhibitor targeting VEGFR and PDGFR. |
| | Pazopanib Related Compound 2 Preparation Products And Raw materials |
|